TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9152292

Group type: EXPERIMENTAL
Intervention: Staple repair
Number of subjects: 88

Group type: COMPARATOR
Intervention: Suture repair
Number of subjects: 88
Study: 8263076

Group type: EXPERIMENTAL
Intervention: 99mTc-bicisate
Number of subjects: 25

Group type: COMPARATOR
Intervention: [123I]IMP
Number of subjects: 25
Study: 3297895

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g/day
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Diethylamine persilate (DAP) 1.5 g/day
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Diethylamine persilate (DAP) 2.5 g/day
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Diethylamine persilate (DAP) 0.5 g/day
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 2035002

Group type: EXPERIMENTAL
Intervention: New organizational routine in the experimental group
Number of subjects: 65

Group type: COMPARATOR
Intervention: Usual routines in the control group
Number of subjects: 65
Study: 1156214

Group type: EXPERIMENTAL
Intervention: Carbidopa plus levodopa
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo plus levodopa
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Carbidopa plus levodopa (non-blind trial)
Number of subjects: 37
Study: 31846016

Group type: EXPERIMENTAL
Intervention: Early intensive and sustained vasodilation (n=386)
Number of subjects: 788

Group type: COMPARATOR
Intervention: Usual care (n=402)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Early intensive and sustained vasodilation
Number of subjects: 788

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 788
Study: 27777038

Group type: EXPERIMENTAL
Intervention: STAND
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: CYCLE
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: WALK
Number of subjects: 9

Group type: COMPARATOR
Intervention: SIT
Number of subjects: 9
Study: 27565118

Group type: COMPARATOR
Intervention: Completely Self-Guided (CSG) Internet-based program
Number of subjects: 296

Group type: COMPARATOR
Intervention: Low-Intensity Therapist-Guided (LITG) Internet-based program
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Improved Treatment as Usual (iTAU)
Number of subjects: 296
Study: 22962030

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sequential add-on treatment
Number of subjects: 34
Study: 23117107

Group type: EXPERIMENTAL
Intervention: Iyengar yoga program (9-week, weekly 90-minute classes)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Self-care/exercise program
Number of subjects: 77
Study: 19443276

Group type: EXPERIMENTAL
Intervention: Teplizumab (anti-CD3 mAb)
Number of subjects: 10
Study: 17205018

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 15086924

Group type: EXPERIMENTAL
Intervention: Calcium supplement taken with meal (1 g of calcium carbonate, 3 times/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Calcium supplement taken at bedtime (3 g/day of calcium carbonate)
Number of subjects: 32
Study: 12173297

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 0
Study: 9391220

Group type: EXPERIMENTAL
Intervention: 150 trials of tactile-thermal application (TTA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 300 trials of tactile-thermal application (TTA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 450 trials of tactile-thermal application (TTA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 600 trials of tactile-thermal application (TTA)
Number of subjects: 0
Study: 7502689

Group type: EXPERIMENTAL
Intervention: Ethinylestradiol 20 micrograms/day + calcium 500 mg/day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Calcium 500 mg/day
Number of subjects: 41
Study: 2091186

Group type: EXPERIMENTAL
Intervention: Electrolyte‐polyethylene glycol solution (SE‐PEG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard bowel preparation (SBP)
Number of subjects: 0
Study: 354046

Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 48

Group type: COMPARATOR
Intervention: Soya-maize porridge
Number of subjects: 48
Study: 31948477

Group type: EXPERIMENTAL
Intervention: Low-magnitude high-frequency vibration (LMHFV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 31099593

Group type: EXPERIMENTAL
Intervention: Knowledge of listeriosis
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Attitude toward listeriosis
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Practice formation regarding listeriosis
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Knowledge-Attitude-Practice (KAP) score
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Association between attitude and knowledge
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Association between practice formation and knowledge
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Correlation of KAP scores with age, occupation, department, and professional title
Number of subjects: 397
Study: 28237552

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional speech therapy
Number of subjects: 15
Study: 25818495

Group type: EXPERIMENTAL
Intervention: Baseline Q waves in men
Number of subjects: 2838

Group type: EXPERIMENTAL
Intervention: Baseline Q waves in women
Number of subjects: 2838

Group type: EXPERIMENTAL
Intervention: Time from symptom onset to PCI in women with baseline Q waves
Number of subjects: 2838
Study: 23652626

Group type: EXPERIMENTAL
Intervention: Better collateral flow at baseline
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Deterioration in collateral quality
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Deterioration in collateral grade
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Deterioration in Tmax hypoperfusion severity
Number of subjects: 88
Study: 21861909

Group type: EXPERIMENTAL
Intervention: Shared medical appointments
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 19930019

Group type: EXPERIMENTAL
Intervention: 2004 Canadian Addictions Survey (CAS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment for non-response bias
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression
Number of subjects: 0
Study: 17709712

Group type: EXPERIMENTAL
Intervention: POTS patients
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: POTS patients with high NE
Number of subjects: 165

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 165
Study: 15096071

Group type: EXPERIMENTAL
Intervention: Venlafaxine, 100 to 200 mg/day for 12 months
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 225
Study: 11774146

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine solution via an infusion pump (2 mL each hour for 48 hours)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline solution via an infusion pump (2 mL each hour for 48 hours)
Number of subjects: 50
Study: 11477812

Group type: EXPERIMENTAL
Intervention: Buyang Huanwu Decoction (BHD) in Chinese medicine group (CMG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Hydroxyethyl starch injection and enteric coated aspirin tablets in western medicine group (WMG)
Number of subjects: 70
Study: 7650234

Group type: EXPERIMENTAL
Intervention: Lidocaine (200 mg) plus adrenalin (1:200,000)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lidocaine (200 mg)
Number of subjects: 10
Study: 2813924

Group type: EXPERIMENTAL
Intervention: Elimination diet and double-blind challenge test
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Physical evaluation of nasal polyposis
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Rhinomanometric evaluation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Immunological tests involving IgE or circulating immunocomplexes
Number of subjects: 22
Study: 47848

Group type: EXPERIMENTAL
Intervention: Outpatient methadone detoxification
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hospital methadone detoxification
Number of subjects: 40
Study: 29858659

Group type: EXPERIMENTAL
Intervention: Gaseous ozone
Number of subjects: 48

Group type: COMPARATOR
Intervention: 2% chlorhexidine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 48
Study: 29454656

Group type: EXPERIMENTAL
Intervention: Listening to music during cast room procedures
Number of subjects: 199

Group type: COMPARATOR
Intervention: No music during cast room procedures
Number of subjects: 199
Study: 26892922

Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg/day for 26 days, then 300 mg/day for 30 days, and 200 mg/day for 31 days)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 29
Study: 24562805

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3602

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 3602

Group type: COMPARATOR
Intervention: Severely impaired LVEF (<40%)
Number of subjects: 3602
Study: 22309385

Group type: EXPERIMENTAL
Intervention: Chin-down posture
Number of subjects: 47
Study: 21073082

Group type: EXPERIMENTAL
Intervention: Single dose of Gentamycin 80 mg IV (immediately after spinal anesthesia)
Number of subjects: 722

Group type: COMPARATOR
Intervention: Extended use of Amoxicillin, Chloramphenicol or Cotrimexazole (postoperatively)
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Single dose of Gentamycin 80 mg IV
Number of subjects: 722

Group type: COMPARATOR
Intervention: Extended use of Amoxicillin, Chloramphenicol or Cotrimexazole
Number of subjects: 722
Study: 17981377

Group type: EXPERIMENTAL
Intervention: Purified duck embryo vaccine (PDEV, Vaxirab)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Purified duck embryo vaccine (Lyssavac)
Number of subjects: 220
Study: 15727886

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 12541217

Group type: EXPERIMENTAL
Intervention: Conventional phototherapy (CPT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Fiberoptic phototherapy (FO-PT)
Number of subjects: 41
Study: 9842767

Group type: EXPERIMENTAL
Intervention: Lesions to the right parahippocampal cortex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lesions to the right hippocampus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lesions to the left hippocampus
Number of subjects: 0
Study: 7859239

Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg theophylline tablet to fasting subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg tablet after a high-fat meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg dose administered as two half tablets to fasting subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 400-mg tablet to fasting subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release theophylline (Slo-Phyllin) 5 x 100 mg to fasting subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 600-mg fasting treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release Uni-Dur 400-mg treatment
Number of subjects: 0
Study: 2570730

Group type: EXPERIMENTAL
Intervention: famotidine (40 mg at bedtime)
Number of subjects: 157

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 157
Study: 786440

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 31082445

Group type: EXPERIMENTAL
Intervention: 3STEPFUN intervention (small group education, foot care kit, booster calls over 6 months)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 3STEPFUN intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Usual care and foot care brochure (control group)
Number of subjects: 119
Study: 28222072

Group type: EXPERIMENTAL
Intervention: Central re-testing of receptor status
Number of subjects: 431
Study: 26130251

Group type: EXPERIMENTAL
Intervention: S-Adenosylmethionine (SAMe) 2.4 g/d for 24 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: S-Adenosylmethionine (SAMe)
Number of subjects: 110
Study: 24277402

Group type: EXPERIMENTAL
Intervention: Enteral plus parenteral nutrition (EN+PN)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Total enteral nutrition (TEN)
Number of subjects: 120
Study: 21615968

Group type: COMPARATOR
Intervention: GP management alone
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: GP management with adjunctive counselling (CBT)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: GP management with adjunctive counselling (CBT) delivered by postnatal nurses or psychologists
Number of subjects: 169
Study: 18362660

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 0.5%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gatifloxacin 0.3%
Number of subjects: 0
Study: 16627675

Group type: EXPERIMENTAL
Intervention: NaHCO3 (Alk-T)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (Pla-T)
Number of subjects: 16
Study: 12752349

Group type: EXPERIMENTAL
Intervention: PAC (pantoprazole 40 mg, clarithromycin 500 mg, amoxicillin 1000 mg)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: PCM (pantoprazole 40 mg, clarithromycin 500 mg, metronidazole 500 mg)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: PAM (pantoprazole 40 mg, amoxicillin 1000 mg, metronidazole 500 mg)
Number of subjects: 519
Study: 10936141

Group type: EXPERIMENTAL
Intervention: Ventilator management protocol (VMP)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Surgical VMP group
Number of subjects: 385

Group type: COMPARATOR
Intervention: Control group (surgical)
Number of subjects: 385

Group type: COMPARATOR
Intervention: Control group (medical)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: VMP and Control groups
Number of subjects: 385
Study: 8820890

Group type: EXPERIMENTAL
Intervention: 22.2 g dibasic calcium phosphate (DCP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Calcium carbonate (placebo)
Number of subjects: 12
Study: 8213584

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 223

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 223

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 223
Study: 3495089

Group type: EXPERIMENTAL
Intervention: Induction 2 mg kg‐1, infusion rate 9 mg kg‐1 h‐1 (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Induction 2.5 mg kg‐1, infusion rate 12 mg kg‐1 h‐1 (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Induction 2.5 mg kg‐1, infusion rate 9 mg kg‐1 (Group 3)
Number of subjects: 30
Study: 31734069

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Thermal ablation
Number of subjects: 750

Group type: COMPARATOR
Intervention: LLETZ
Number of subjects: 750
Study: 29959288

Group type: EXPERIMENTAL
Intervention: Zoom2 (Z) with light activation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Boost (B) without light activation
Number of subjects: 60
Study: 25496482

Group type: EXPERIMENTAL
Intervention: Avoidance plan (radiotherapy optimized to minimize dose to functional lung)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard plan (radiotherapy without reference to functional lung state)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Avoidance plan
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard plan
Number of subjects: 64
Study: 22261206

Group type: EXPERIMENTAL
Intervention: Cybercycling (virtual reality tours on a recumbent stationary ergometer)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Traditional exercise
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cybercycling
Number of subjects: 102
Study: 20305044

Group type: EXPERIMENTAL
Intervention: Fast track intervention (FI) - multiprofessional palliative care team assessment and follow-up
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard intervention (SI) - best standard care followed by palliative care team after 3 months
Number of subjects: 52
Study: 18354721

Group type: EXPERIMENTAL
Intervention: Local anesthetic lumbar facet joint nerve blocks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Local anesthetic and steroid lumbar facet joint nerve blocks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 120
Study: 15849292

Group type: EXPERIMENTAL
Intervention: Athletes
Number of subjects: 300

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 300
Study: 12414409

Group type: EXPERIMENTAL
Intervention: 100 mM trehalose
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 200 mM trehalose
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control saline
Number of subjects: 34
Study: 10494113

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Bladder training
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Combination training (both pelvic floor muscle training and bladder training)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 204
Study: 7563511

Group type: EXPERIMENTAL
Intervention: Percentage of free PSA in serum in men with cancer and a normal‐sized gland
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Percentage of free PSA in serum in men with cancer and an enlarged gland
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Percentage of free PSA in serum in men with benign prostatic hyperplasia
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Free PSA cutoff in men with an enlarged, palpably benign gland
Number of subjects: 113
Study: 2083477

Group type: EXPERIMENTAL
Intervention: Water Pik Automatic Toothbrush
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Interplak brush
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual brushing
Number of subjects: 30
Study: 368354

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride 200 mg daily
Number of subjects: 0
Study: 31522846

Group type: EXPERIMENTAL
Intervention: Laparoscopic supracervical hysterectomy
Number of subjects: 660

Group type: COMPARATOR
Intervention: Endometrial ablation
Number of subjects: 660
Study: 27770836

Group type: EXPERIMENTAL
Intervention: kJ/100g food label
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HSR label
Number of subjects: 0

Group type: COMPARATOR
Intervention: No information on nutrient composition
Number of subjects: 0
Study: 25755135

Group type: EXPERIMENTAL
Intervention: Low acculturation (SASH score < 3)
Number of subjects: 398
Study: 23569021

Group type: EXPERIMENTAL
Intervention: High spinal anaesthesia with midazolam and fentanyl in older patients
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High spinal anaesthesia without midazolam and fentanyl in older patients
Number of subjects: 90

Group type: COMPARATOR
Intervention: High spinal anaesthesia in younger patients
Number of subjects: 90
Study: 22008819

Group type: EXPERIMENTAL
Intervention: HRV vaccine (Rotarix™)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Transmission cases
Number of subjects: 200
Study: 19276131

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl
Number of subjects: 1266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1266
Study: 16620739

Group type: EXPERIMENTAL
Intervention: Checkpoints Program (intervention)
Number of subjects: 3743

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 3743
Study: 15452023

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (fish oil)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Olive oil capsules (control)
Number of subjects: 18
Study: 11385189

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen therapy (TET)
Number of subjects: 7
Study: 9092956

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) at target dosages of 200-1,000 mg daily
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 534

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 534
Study: 7706568

Group type: EXPERIMENTAL
Intervention: Predictive model including variables of acute physiology and Glasgow Coma Score
Number of subjects: 901

Group type: COMPARATOR
Intervention: Predictive model consisting of Glasgow Coma Score, age, diagnosis of head injury, and type of ICU admission
Number of subjects: 901
Study: 3423501

Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no plasma exchange)
Number of subjects: 0
Study: 28913575

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 0
Study: 26808585

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 15245

Group type: EXPERIMENTAL
Intervention: New-onset diabetic patients
Number of subjects: 15245

Group type: EXPERIMENTAL
Intervention: Non-diabetic patients
Number of subjects: 15245
Study: 26631161

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined cognitive intervention (ACoTrain)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (individual rehabilitation programme)
Number of subjects: 60
Study: 23731073

Group type: COMPARATOR
Intervention: Devaluation of UCS (decreased intensity after acquisition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inflation of UCS (increased intensity after acquisition)
Number of subjects: 0
Study: 20613542

Group type: EXPERIMENTAL
Intervention: 80% oxygen (group A)
Number of subjects: 53
Study: 18853696

Group type: EXPERIMENTAL
Intervention: Dietary intake with RDI >= 50
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Dietary intake among women with RDI >= 50
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Caloric expenditure with RDI >= 50
Number of subjects: 320